Skip to main content
Top
Published in: Journal of Cancer Education 5/2022

18-02-2021 | Care

Building Cancer Prevention and Control Research Capacity in Rural Appalachian Kentucky Primary Care Clinics During COVID-19: Development and Adaptation of a Multilevel Colorectal Cancer Screening Project

Authors: Aaron J. Kruse-Diehr, Mark Dignan, Mark Cromo, Angela L. Carman, Melinda Rogers, David Gross, Sue Russell

Published in: Journal of Cancer Education | Issue 5/2022

Login to get access

Abstract

This study describes the development of a colorectal cancer (CRC) screening multilevel intervention with four primary care clinics in rural Appalachian Kentucky. We also discuss barriers experienced by the clinics during COVID-19 and how clinic limitations and needs informed project modifications. Four primary care clinics were recruited, key informant interviews with clinic providers were conducted, electronic health record (EHR) capacity to collect data related to CRC screening and follow-up was assessed, and a series of meetings were held with clinic champions to discuss implementation of strategies to impact clinic CRC screening rates. Analysis of interviews revealed multilevel barriers to CRC screening. Patient-level barriers included fatalism, competing priorities, and financial and literacy concerns. The main provider- and clinic-level barriers were provider preference for colonoscopy over stool-based testing and EHR tracking concerns. Clinics selected strategies to address barriers, but the onset of COVID-19 necessitated modifications to these strategies. Due to COVID-19, changes in clinic staffing and workflow occurred, including provider furloughs, a state-mandated pause in elective procedures, and an increase in telehealth. Clinics adapted screening strategies to match changing needs, including shifting from paper to digital educational tools and using telehealth to increase annual wellness visits for screening promotion. While significant delays persist for scheduling colonoscopies, clinics were encouraged to promote stool-based tests as a primary screening modality for average-risk patients.
Literature
1.
go back to reference Siegel RL, Sahar L, Robbins A, Jemal A (2015) Where can colorectal cancer screening interventions have the most impact? Cancer Epidemiol Biomarkers Prev 24(8):1151–1156CrossRef Siegel RL, Sahar L, Robbins A, Jemal A (2015) Where can colorectal cancer screening interventions have the most impact? Cancer Epidemiol Biomarkers Prev 24(8):1151–1156CrossRef
3.
go back to reference Appalachian Regional Development Act Amendments of 2007 (2007) Rep. Oberstar JLD-M-, trans. H.R.799. 110th ed Appalachian Regional Development Act Amendments of 2007 (2007) Rep. Oberstar JLD-M-, trans. H.R.799. 110th ed
4.
go back to reference Wilson RJ, Ryerson AB, Singh SD, King JB (2016) Cancer incidence in Appalachia, 2004-2011. Cancer Epidemiol Biomarkers Prev 25(2):250–258CrossRef Wilson RJ, Ryerson AB, Singh SD, King JB (2016) Cancer incidence in Appalachia, 2004-2011. Cancer Epidemiol Biomarkers Prev 25(2):250–258CrossRef
5.
go back to reference US Cancer Statistics Working Group (2017) United States Cancer Statistics: 1999 - 2014 Incidence and mortality web-based report. US Department of Health and Human Services, Atlanta GA US Cancer Statistics Working Group (2017) United States Cancer Statistics: 1999 - 2014 Incidence and mortality web-based report. US Department of Health and Human Services, Atlanta GA
6.
go back to reference Arnold CL, Rademaker A, Liu D, Davis TC (2017) Changes in colorectal cancer screening knowledge, behavior, beliefs, self-efficacy, and barriers among community health clinic patients after a health literacy intervention. J Community Med Healthl Educ 7(1):497 Arnold CL, Rademaker A, Liu D, Davis TC (2017) Changes in colorectal cancer screening knowledge, behavior, beliefs, self-efficacy, and barriers among community health clinic patients after a health literacy intervention. J Community Med Healthl Educ 7(1):497
7.
go back to reference Arnold CL, Rademaker A, Wolf MS, Liu D, Hancock J, Davis TC (2016) Third annual fecal occult blood testing in community health clinics. Am J Health Behav 40(3):302–309CrossRef Arnold CL, Rademaker A, Wolf MS, Liu D, Hancock J, Davis TC (2016) Third annual fecal occult blood testing in community health clinics. Am J Health Behav 40(3):302–309CrossRef
8.
go back to reference Honeycutt S, Green R, Ballard D, Hermstad A, Brueder A, Haardörfer R, Yam J, Arriola KJ (2013) Evaluation of a patient navigation program to promote colorectal cancer screening in rural Georgia, USA. Cancer 119(16):3059–3066CrossRef Honeycutt S, Green R, Ballard D, Hermstad A, Brueder A, Haardörfer R, Yam J, Arriola KJ (2013) Evaluation of a patient navigation program to promote colorectal cancer screening in rural Georgia, USA. Cancer 119(16):3059–3066CrossRef
13.
go back to reference Vanderpool RC, Moore SC, Stradtman LR, Carman AL, Kurgat HL, Fain P (2016) Adaptation of an evidence-based intervention to improve preventive care practices in a federally qualified health center in Appalachian Kentucky. J Health Care Poor Underserved 27(4A):46–52CrossRef Vanderpool RC, Moore SC, Stradtman LR, Carman AL, Kurgat HL, Fain P (2016) Adaptation of an evidence-based intervention to improve preventive care practices in a federally qualified health center in Appalachian Kentucky. J Health Care Poor Underserved 27(4A):46–52CrossRef
14.
go back to reference Dignan M, Shelton B, Slone SA, Tolle C, Mohammad S, Schoenberg N, Pearce K, van Meter E, Ely G (2014) Effectiveness of a primary care practice intervention for increasing colorectal cancer screening in Appalachian Kentucky. Prev Med 58:70–74CrossRef Dignan M, Shelton B, Slone SA, Tolle C, Mohammad S, Schoenberg N, Pearce K, van Meter E, Ely G (2014) Effectiveness of a primary care practice intervention for increasing colorectal cancer screening in Appalachian Kentucky. Prev Med 58:70–74CrossRef
15.
go back to reference Baltic RD, Weier RC, Katz ML, Kennedy SK, Lengerich EJ, Lesko SM, Reese D, Roberto KA, Schoenberg NE, Young GS, Dignan MB, Paskett ED (2015) Study design, intervention, and baseline characteristics of a group randomized trial involving a faith-based healthy eating and physical activity intervention (Walk by Faith) to reduce weight and cancer risk among overweight and obese Appalachian adults. Contemp Clin Trials 44:1–10CrossRef Baltic RD, Weier RC, Katz ML, Kennedy SK, Lengerich EJ, Lesko SM, Reese D, Roberto KA, Schoenberg NE, Young GS, Dignan MB, Paskett ED (2015) Study design, intervention, and baseline characteristics of a group randomized trial involving a faith-based healthy eating and physical activity intervention (Walk by Faith) to reduce weight and cancer risk among overweight and obese Appalachian adults. Contemp Clin Trials 44:1–10CrossRef
19.
go back to reference Kemper KE, Glaze BL, Eastman CL, Waldron RC, Hoover S, Flagg T’R, Tangka FKL, Subramanian S (2018) Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washingston state. Cancer 124(21):4121–4129CrossRef Kemper KE, Glaze BL, Eastman CL, Waldron RC, Hoover S, Flagg T’R, Tangka FKL, Subramanian S (2018) Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washingston state. Cancer 124(21):4121–4129CrossRef
20.
go back to reference Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, Muñoz R, Lau C, Somsouk M, el-Nachef N, Hayward RA (2012) Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172(7):575–582CrossRef Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, Muñoz R, Lau C, Somsouk M, el-Nachef N, Hayward RA (2012) Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172(7):575–582CrossRef
21.
go back to reference Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ (2009) Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med 169(4):364–371CrossRef Sequist TD, Zaslavsky AM, Marshall R, Fletcher RH, Ayanian JZ (2009) Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med 169(4):364–371CrossRef
23.
go back to reference Jiang M, Hughes DR, Wang W (2018) The effect of Medicare’s annual wellness visit on preventive care for the elderly. Prev Med 116:126–133CrossRef Jiang M, Hughes DR, Wang W (2018) The effect of Medicare’s annual wellness visit on preventive care for the elderly. Prev Med 116:126–133CrossRef
24.
go back to reference Camacho F, Yao N, Anderson R (2017) The effectiveness of Medicare wellness visits in accessing preventive screening. J Prim Care Community Health 8(4):247–255CrossRef Camacho F, Yao N, Anderson R (2017) The effectiveness of Medicare wellness visits in accessing preventive screening. J Prim Care Community Health 8(4):247–255CrossRef
28.
31.
go back to reference Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI (2020) A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med 172(11):756–758CrossRef Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI (2020) A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med 172(11):756–758CrossRef
34.
go back to reference Balzora S, Issaka RB, Anyane-Yeboa A, Gray DM 2nd, May FP (2020) Impact of COVID-19 on colorectal cancer disparities and the way forward. Gastrointest Endosc 92(4):946–950CrossRef Balzora S, Issaka RB, Anyane-Yeboa A, Gray DM 2nd, May FP (2020) Impact of COVID-19 on colorectal cancer disparities and the way forward. Gastrointest Endosc 92(4):946–950CrossRef
35.
go back to reference Nodora JN, Gupta S, Howard N, Motadel K, Propst T, Rodriguez J, Schultz J, Velasquez S, Castañeda SF, Rabin B, Martínez ME (2020) The COVID-19 pandemic: identifying adaptive solutions for colorectal cancer screening in underserved communities. J Natl Cancer Inst. https://doi.org/10.1092/jnci/djaa117 Nodora JN, Gupta S, Howard N, Motadel K, Propst T, Rodriguez J, Schultz J, Velasquez S, Castañeda SF, Rabin B, Martínez ME (2020) The COVID-19 pandemic: identifying adaptive solutions for colorectal cancer screening in underserved communities. J Natl Cancer Inst. https://​doi.​org/​10.​1092/​jnci/​djaa117
36.
go back to reference Cohen DJ, Crabtree BJ, Etz RS et al (2008) Fidelity versus flexibility: translating evidence-based research into practice. Am J Prev Med 35(5 Suppl):S381–S389CrossRef Cohen DJ, Crabtree BJ, Etz RS et al (2008) Fidelity versus flexibility: translating evidence-based research into practice. Am J Prev Med 35(5 Suppl):S381–S389CrossRef
37.
go back to reference Balasubramanian BA, Cohen DJ, Davis MM et al (2015) Learning evaluation: blending quality improvement and implementation research methods to study heatlhcare innovations. Imp Sci 10:31 Balasubramanian BA, Cohen DJ, Davis MM et al (2015) Learning evaluation: blending quality improvement and implementation research methods to study heatlhcare innovations. Imp Sci 10:31
38.
go back to reference Ramanadhan S, Davis MM, Armstrong R, Baquero B, Ko LK, Leng JC, Salloum RG, Vaughn NA, Brownson RC (2018) Participatory implementation science to increase the impact of evidence-based cancer prevention and control. Cancer Causes Control 29(3):363–369CrossRef Ramanadhan S, Davis MM, Armstrong R, Baquero B, Ko LK, Leng JC, Salloum RG, Vaughn NA, Brownson RC (2018) Participatory implementation science to increase the impact of evidence-based cancer prevention and control. Cancer Causes Control 29(3):363–369CrossRef
39.
go back to reference Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A (2012) Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366(8):697–706CrossRef Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A (2012) Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366(8):697–706CrossRef
Metadata
Title
Building Cancer Prevention and Control Research Capacity in Rural Appalachian Kentucky Primary Care Clinics During COVID-19: Development and Adaptation of a Multilevel Colorectal Cancer Screening Project
Authors
Aaron J. Kruse-Diehr
Mark Dignan
Mark Cromo
Angela L. Carman
Melinda Rogers
David Gross
Sue Russell
Publication date
18-02-2021
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 5/2022
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-021-01972-w

Other articles of this Issue 5/2022

Journal of Cancer Education 5/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine